Terms: = Prostate cancer AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546
122 results:
1. Incidence and risk factors of prostate cancer among the Northern and Eastern parts of the United Arab Emirates population.
Al Shareef Z; Al-Shahrabi R; Saheb Sharif-Askari F; AlDhmanie A; Alshamsi Y; Zarooni AA; Mahmoud RA; Soliman SSM; Halwani R; Bendardaf R
Prostate; 2024 Feb; 84(2):185-192. PubMed ID: 37969038
[TBL] [Abstract] [Full Text] [Related]
2. Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive prostate cancer.
Darst BF; Saunders E; Dadaev T; Sheng X; Wan P; Pooler L; Xia LY; Chanock S; Berndt SI; Wang Y; Patel AV; Albanes D; Weinstein SJ; Gnanapragasam V; Huff C; Couch FJ; Wolk A; Giles GG; Nguyen-Dumont T; Milne RL; Pomerantz MM; Schmidt JA; Travis RC; Key TJ; Stopsack KH; Mucci LA; Catalona WJ; Marosy B; Hetrick KN; Doheny KF; MacInnis RJ; Southey MC; Eeles RA; Wiklund F; Conti DV; Kote-Jarai Z; Haiman CA
JAMA Oncol; 2023 Nov; 9(11):1514-1524. PubMed ID: 37733366
[TBL] [Abstract] [Full Text] [Related]
3. Costs of radium-223 and the pharmacy preparation
Quist SW; Paulissen JHJ; Wyndaele DNJ; Nagarajah J; Freriks RD
J Med Econ; 2023; 26(1):366-375. PubMed ID: 36905581
[TBL] [Abstract] [Full Text] [Related]
4. Pan-cancer association of DNA repair deficiencies with whole-genome mutational patterns.
Sørensen SG; Shrikhande A; Poulsgaard GA; Christensen MH; Bertl J; Laursen BE; Hoffmann ER; Pedersen JS
Elife; 2023 Mar; 12():. PubMed ID: 36883553
[TBL] [Abstract] [Full Text] [Related]
5. Acute toxicity and health-related quality of life outcomes of localized prostate cancer patients treated with magnetic resonance imaging-guided high-dose-rate brachytherapy: A prospective phase II trial.
Sanmamed N; Adleman J; Berlin A; Borg J; Lao B; Weersink R; Simeonov A; Rink A; Beiki-Ardakani A; Menard C; Chung P; Helou J
Brachytherapy; 2023; 22(1):58-65. PubMed ID: 36414526
[TBL] [Abstract] [Full Text] [Related]
6. The 2018 World cancer Research Fund/American Institute for cancer Research Score and cancer Risk: A Longitudinal Analysis in the NIH-AARP Diet and Health Study.
Korn AR; Reedy J; Brockton NT; Kahle LL; Mitrou P; Shams-White MM
Cancer Epidemiol Biomarkers Prev; 2022 Oct; 31(10):1983-1992. PubMed ID: 35877953
[TBL] [Abstract] [Full Text] [Related]
7. Addition of Docetaxel to Androgen Receptor Axis-targeted Therapy and Androgen Deprivation Therapy in Metastatic Hormone-sensitive prostate cancer: A Network Meta-analysis.
Roy S; Sayyid R; Saad F; Sun Y; Lajkosz K; Ong M; Klaassen Z; Malone S; Spratt DE; Wallis CJD; Morgan SC
Eur Urol Oncol; 2022 Oct; 5(5):494-502. PubMed ID: 35811293
[TBL] [Abstract] [Full Text] [Related]
8. Head-To-Head Comparison of
Zhao G; Ji B
AJR Am J Roentgenol; 2022 Sep; 219(3):386-395. PubMed ID: 35441529
[No Abstract] [Full Text] [Related]
9. A critical analysis of deficiencies in the quality of information contained in prostate multiparametric MRI requests and reports.
Cullivan O; Roche E; Hegazy M; Taha M; Durkan G; O'Malley P; McCarthy P; Dowling CM
Ir J Med Sci; 2023 Feb; 192(1):27-31. PubMed ID: 35094231
[TBL] [Abstract] [Full Text] [Related]
10. Pan-cancer Analysis of Homologous Recombination Repair-associated Gene Alterations and Genome-wide Loss-of-Heterozygosity Score.
Westphalen CB; Fine AD; André F; Ganesan S; Heinemann V; Rouleau E; Turnbull C; Garcia Palacios L; Lopez JA; Sokol ES; Mateo J
Clin Cancer Res; 2022 Apr; 28(7):1412-1421. PubMed ID: 34740923
[TBL] [Abstract] [Full Text] [Related]
11. Poor clinical guideline adherence and inappropriate testing for incident lower urinary tract symptoms associated with benign prostatic hyperplasia.
Welliver C; Feinstein L; Ward JB; Kirkali Z; Martinez-Miller EE; Matlaga BR; McVary K
Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):269-273. PubMed ID: 34545201
[TBL] [Abstract] [Full Text] [Related]
12. Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial.
Sweeney C; Bracarda S; Sternberg CN; Chi KN; Olmos D; Sandhu S; Massard C; Matsubara N; Alekseev B; Parnis F; Atduev V; Buchschacher GL; Gafanov R; Corrales L; Borre M; Stroyakovskiy D; Alves GV; Bournakis E; Puente J; Harle-Yge ML; Gallo J; Chen G; Hanover J; Wongchenko MJ; Garcia J; de Bono JS
Lancet; 2021 Jul; 398(10295):131-142. PubMed ID: 34246347
[TBL] [Abstract] [Full Text] [Related]
13. Re-evaluating tumors of purported specialized prostatic stromal origin reveals molecular heterogeneity, including non-recurring gene fusions characteristic of uterine and soft tissue sarcoma subtypes.
Acosta AM; Sholl LM; Dickson BC; McKenney JK; Gordetsky JB; Pins MR; Marino-Enriquez A; Dong F; Dubuc AM; Cin PD; Fletcher CDM
Mod Pathol; 2021 Sep; 34(9):1763-1779. PubMed ID: 33986460
[TBL] [Abstract] [Full Text] [Related]
14. Multiparametric Magnetic Resonance Imaging-Based Peritumoral Radiomics for Preoperative Prediction of the Presence of Extracapsular Extension With prostate cancer.
Bai H; Xia W; Ji X; He D; Zhao X; Bao J; Zhou J; Wei X; Huang Y; Li Q; Gao X
J Magn Reson Imaging; 2021 Oct; 54(4):1222-1230. PubMed ID: 33970517
[TBL] [Abstract] [Full Text] [Related]
15. The Influence of Endogenous Testosterone on Incidental prostate cancer after Transurethral prostate Resection.
Porcaro AB; Siracusano S; Amigoni N; Tafuri A; Rizzetto R; Shakir A; Tiso L; Cerrato C; De Michele M; Bianchi A; Gallina S; Brunelli M; Migliorini F; Artibani W; Antonelli A
Urol Int; 2021; 105(9-10):826-834. PubMed ID: 33965959
[TBL] [Abstract] [Full Text] [Related]
16. Is Thiol/Disulphide homeostasis important in prostate cancer diagnosis?
Senel C; Aslan Y; Imamoglu MA; Karakoyunlu AN; Altinova S; Ozcan MF; Erdogan S; Balci M; Tuncel A
Arch Esp Urol; 2020 Nov; 73(9):819-825. PubMed ID: 33144536
[TBL] [Abstract] [Full Text] [Related]
17. A 5-Item Frailty Index for Predicting Morbidity and Mortality After Radical prostatectomy: An Analysis of the American College of Surgeons National Surgical Quality Improvement Program Database.
Shahait M; Labban M; Dobbs RW; Cheaib JG; Lee DI; Tamim H; El-Hajj A
J Endourol; 2021 Apr; 35(4):483-489. PubMed ID: 32935596
[No Abstract] [Full Text] [Related]
18. prostate specific antigen test uptake: a cross sectional study on elderly men in Western Iran.
Mirzaei-Alavijeh M; Jalilian F; Solaimanizadeh L; Saadatfar A; Khashij S; Pirouzeh R; Solaimanizadeh F
BMC Geriatr; 2020 Aug; 20(1):298. PubMed ID: 32831024
[TBL] [Abstract] [Full Text] [Related]
19. Improving identification of candidates for lung cancer screening in a high risk population.
Waddle MR; Ko SJ; May J; Kaleem T; Miller DH; Stross WC; Malouff TD; Wert K; Cuthbert K; Landy R; Strong G; Vallow LA; Johnson MM
Lung Cancer; 2020 Oct; 148():79-85. PubMed ID: 32827761
[TBL] [Abstract] [Full Text] [Related]
20. Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment.
Fumet JD; Limagne E; Thibaudin M; Truntzer C; Bertaut A; Rederstorff E; Ghiringhelli F
BMC Cancer; 2020 Aug; 20(1):748. PubMed ID: 32778095
[TBL] [Abstract] [Full Text] [Related]
[Next]
